Skip to main content
. 2018 Oct 25;7(2):307–319. doi: 10.1007/s40120-018-0114-z

Fig. 1.

Fig. 1

Mean change from baseline in MDS-UPDRS-III total score [least-squares mean (90%CI)] and subscale scores [arithmetic mean (80%CI)] at day 1 in the SAD study 9 mg cohort. CI confidence interval, SAD single ascending dose, MDS-UPDRS-III Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale Part III